Table 1.

In vivo bioaccessibility of fucoxanthin in rodents: Maxima concentration determined in different tissues and plasma.

Dose	Plasma			Liver			Adipose Tissue			Ref.
	F 7	FxOH	AxA	F	FxOH	AxA	F	FxOH	AxA
1.5 nmol FxOH s.d. 1 i.v. 2		29.1 pmol/mL	17.2 pmol/mL		108.9 pmol/g	18.2 pmol/g				[29]
160 nmol F s.d. i.g. 3		132 nmol/L	230 nmol/L		584 nmol/g	190 nmol/g		39 nmol/g	84 nmol/g	[36]
160 nmol/d F 7 d i.g.		45 nmol/L	82 nmol/L	15 nmol/g	83 nmol/g	40 nmol/g	23.1 nmol/g	60 nmol/g	97 nmol/g	[36]
40 nmol F s.d. i.s. 4		0.4 nmol/L								[28]
0.05% F 5 w diet 5					78.1 µg/g protein	64.7 µg/g protein				[38]
0.128 mmol/d F 14 d diet 5		0.34 µmol/L	0.95 µmol/L		0.85 µmol/kg	0.96 µmol/kg		2.14 µmol/kg	7.85 µmol/kg	[34]
3.1 µmol F s.d. d.i. 6		0.33 µmol 8								[39]
3.2 µmol FxOH s.d. d.i.		0.44 µmol 8								[39]
2 mg/kg F s.d. i.v.	14,000 µg/L	598.2 µg/L								[40]
65 mg/kg F s.d. i.g.	29.1 µg/L	263.3 µg/L								[40]
7 mg/kg F s.d.	18.8 nmol/L	68.6 nmol/L								[41]

¹ s.d.: single dose; ² i.v.: intravenous; ³ i.g.: intragastrically; ⁴ i.s.: intubation in the stomach; ⁵ ”ad libitum” diet; ⁶ d.i.: duodenal infusion; ⁷ F: fucoxanthin, FxOH: fucoxanthinol, AxA: Amarouciaxanthin A.; ⁸ Detected in lymph but not in plasma.